Fusion Pharmaceuticals Inc.
SEC CIK 1805890 · FUSN · last insider filing 2024-06-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cagnoni Pablo J | Director | filed 2020 - 2024 |
| Duncan Barbara Gayle | Director | filed 2020 - 2024 |
| Meek David D. | Director | filed 2023 - 2024 |
| Gannon Steven | Director | filed 2020 - 2024 |
| Bergstrom Donald A | Director | filed 2021 - 2024 |
| Valliant John | Director · Chief Executive Officer | filed 2020 - 2024 |
| Lee Philina | Director | filed 2021 - 2024 |
| Bender Jeremy | Director | filed 2023 - 2024 |
| Bitetti Teresa Marie | Director | filed 2023 - 2024 |
| Preston Heather | Director | filed 2020 - 2023 |
| Khuong Chau Quang | Director | filed 2020 - 2023 |
| Orbimed Advisors LLC | Director | filed 2020 - 2020 |
| Orbimed Capital LLC | Director | filed 2020 - 2020 |
| Christenson Johan | Director | filed 2020 - 2020 |
| Orbimed Capital GP VII LLC | Director | filed 2020 - 2020 |
| Lamb Damian | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Leamon Christopher P | Chief Scientific Officer | filed 2021 - 2024 |
| Crowley John J | Chief Financial Officer | filed 2020 - 2024 |
| Burak Eric | Chief? Scientific Officer | filed 2020 - 2024 |
| Rawat Mohit | President and CBO | filed 2021 - 2024 |
| Bobilev Dmitri | Chief Medical Officer | filed 2022 - 2024 |
| O'Leary James J | Chief Medical Officer | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.